from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1594/nadA

LFCtreatmentdescriptionclass of inhibitor

-0.276

Amikacinug/mL Amikacintranslation

-2.060

Cap5-10ug/mL Capreomycintranslation

-1.885

Rox10-50 ug/mL Roxithromycintranslation

0.544

SM2-5 ug/mL Streptomycintranslation

-1.531

Tet5-10 ug/mL Tetracyclinetranslation

-0.961

Rif0.2-5ug/mL Rifampicintranscription

-1.539

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.685

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.050

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.620

CPZ10-50 ug/mL Chlorpromazinerespiration

0.458

Clofazimine10-13 ug/mL Clofaziminerespiration

0.041

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.639

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.014

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.943

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.032

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.111

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.641

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.029

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.663

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.718

KCN5-20 ug/mL Potassium cyaniderespiration

0.508

NaN30.2-2 mM Sodium aziderespiration

-1.090

Nigericin50 uM Nigericinrespiration

-1.468

TRC10-150 ug/mL Triclosanrespiration

0.983

TRZ10-25 ug/mL Thioridazinerespiration

1.126

Valinomycin0.5-10 uM Valinomycinrespiration

-0.253

ZnSO42 mM ZnSO4respiration

-0.421

menadione6-10 ug/mL Menadionerespiration

-0.155

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.400

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.045

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.470

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.764

NRP_1Non-replicating persistence stage 1dosRassociated

0.604

Amp0.2mg/mL AmpicillincellWall

0.240

Cephalexin20-100 ug/mL CephalexincellWall

0.072

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.251

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.086

EMB10-20 ug/mL EthambutolcellWall

1.761

Eta12-40 ug/mL EthionamidecellWall

1.463

INH0.2-0.4 ug/mL IsoniazidcellWall

0.790

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.443

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.005

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.600

BZA0.12 mg/mL BenzamidearomaticAmides

-0.190

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.061

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.078

H2O24 mM hydrogen peroxideDNAdamaging

-0.490

Levo10 ug/mL LevofloxacinDNAdamaging

0.244

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.314

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.008

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.065

UVUV-irradiationDNAdamaging

1.204

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.364

Antimycin12.5-50 ug/mL Antimycin A?

-0.764

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.519

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.094

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.022

PA8240.2-2 ug/mL PA-824?

1.783

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.254

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.808

Verapamil50 uM Verapamil?

-1.003

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.782

methoxatin10-20 ug/mL Methoxatin?